Skip to main content
. 2025 May 5;30(7):1426–1435. doi: 10.1007/s10147-025-02772-8

Table 4.

Outcomes of All Patients

Clinically Significant Events Requiring Treatment N, % BMI < 30 (n = 117) BMI ≥ 30 (n = 80) P
EMCa recurrence (including pT2,3) 5 2.5% 3 2 1.0
Cancer-specfic death 2 1% 2 0
Disease-free survival 3 1.5% 1 2
Other organ cancer 6 3% 5 1* 0.429
Lifestyle-related diseases 11 5.6% 3 8 0.055
Initiation of dialysis 2 1% 2 0
Thrombosis 2 1% 0 2
Diabetes, liver disease, etc 7 3.5% 1 6
Fractures/orthopedic surgery 3 1.5% 1 2 -
Others 2 1% 2 0 -
Total 27 13 14

EMCa endometrial cancer, A A patient with a BMI of 53 developed lung cancer. Subsequently, their BMI increased to 60, leading to worsening respiratory impairment due to severe obesity. This made treatment challenging, and the patient unfortunately passed away